Adoptive immunotherapy using donor liver NK cells for preventing recurrence of hepatocellular carcinoma after liver transplantation

Adoptive immunotherapy using donor liver NK cells for preventing recurrence of hepatocellular carcinoma after liver transplantation - Liver NK cell immunotherapy for liver transplant patients with HCC

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012162

Enrollment

Registered

2013-10-29

Start date

2006-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Adoptive transfer of donor liver NK cells

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult liver transplant patients with HCC

Exclusion criteria

Exclusion criteria: No HCC patients

Design outcomes

Primary

Measure	Time frame
Recurrent free survival	—

Secondary

Measure	Time frame
Overall survival Rejection rate Infection rate	—

Countries

Japan

Contacts

Public ContactMasahiro Ohira

Hiroshima University Gastroenterology and transplant surgery

mohira@hiroshima-u.ac.jp082-257-5222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026